The most recent KDIGO guidelines (2017) for the management of CKD-MBD state the importance to monitor serum levels of calcium, phosphate, and PTH at the beginning of CKD stage G3a, and to evaluate their trends over time, as well as suggesting measuring levels of 25(OH)D to diagnose vitamin D deficiency. The gene discussed is PTH; the disease is chronic kidney disease.